[Glucocorticoid-induced osteoporosis].
Ohnaka
Keizo
K
Department of Geriatric Medicine, Graduate School of Medical Sciences, Kyushu University.
Takayanagi
Ryoichi
R
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D003864:Depression, Chemical; D004164:Diphosphonates / Q000627:therapeutic use; D004967:Estrogens / Q000378:metabolism; D005938:Glucocorticoids / Q000009:adverse effects* / Q000502:physiology; D006801:Humans; D008019:Life Style; D010006:Osteoblasts / Q000166:cytology; D010024:Osteoporosis / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D013739:Testosterone / Q000378:metabolism
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004967:Estrogens; D005938:Glucocorticoids; D013739:Testosterone; D002118:Calcium